» Articles » PMID: 36344029

Specific Management of Lipodermatosclerosis (sclerotic Hypodermitis) in Acute and Chronic Phase

Overview
Journal J Med Vasc
Publisher Elsevier
Date 2022 Nov 7
PMID 36344029
Authors
Affiliations
Soon will be listed here.
Abstract

Lipodermatosclerosis or sclerotic hypodermitis is presented as a complication of venous insufficiency and in particular of post-thrombotic syndrome with a high risk of progression to leg ulcers. However, it has also been described in obese patients without venous insufficiency, and even in the course of various systemic diseases including scleroderma. It most often affects middle-aged women and is usually bilateral, with a typically "inverted champagne bottle" leg appearance. The pathogenic role of venous hypertension explains why compression with bands or stockings is the basis of treatment. In acute phase, which may precede or complicate chronic forms, the pain is so severe that compression is not tolerated. In acute phase, non-steroidal anti-inflammatory drugs, intra-lesional use of triamcinolone, and capsaicin transdermal patches indicated for neuropathic pain have been proposed. In chronic forms, the treatment of superficial venous insufficiency and/or incontinent perforating veins, documented during a Duplex ultrasound scan, is usually proposed, whenever possible. In association with elastic compression, pentoxifylline and colchicine have been used without clear evidence of clinical efficacy. Finally, in the most advanced clinical presentation with the appearance of a sclerotic gaiter associated with ulcerations, surgical treatment with excision-cutaneous grafting associated or not with perforating veins ligation and a fasciotomy may be discussed as a last resort for treatment.

Citing Articles

Panniculitis: a narrative review.

Maniam G, Limmer E, Gibson L, Tolkachjov S, Alavi A Arch Dermatol Res. 2025; 317(1):373.

PMID: 39921712 DOI: 10.1007/s00403-025-03816-9.


Approach to the Atypical Wound.

Becker S, Kody S, Fett N, Hines A, Alavi A, Ortega-Loayza A Am J Clin Dermatol. 2024; 25(4):559-584.

PMID: 38744780 DOI: 10.1007/s40257-024-00865-0.